by divibasicbldev | Nov 23, 2021 | Press Releases
Pasithea Clinics is one of only three accredited clinics in the U.K. approved to offer esketamine nasal spray (SPRAVATO®) for treatment of mental health disordersMIAMI BEACH, Fla., Nov. 23, 2021 (GLOBE NEWSWIRE) — Pasithea Therapeutics Corp. (Nasdaq: KTTA)...
by divibasicbldev | Nov 17, 2021 | Press Releases
— Pasithea Clinics to offer ketamine infusion therapy for the treatment of mental health disorders — — First mobile clinics launch in New York City, Los Angeles, San Diego, and San Francisco, with expansion to additional U.S. cities in coming months...
by divibasicbldev | Nov 11, 2021 | Press Releases
— Music plays an important role in ketamine therapy and is known to facilitate positive outcomes –MIAMI BEACH, Fla., Nov. 11, 2021 (GLOBE NEWSWIRE) — Pasithea Therapeutics Corp. (Nasdaq: KTTA) (Pasithea or the Company), a novel biotechnology company...
by divibasicbldev | Nov 9, 2021 | Press Releases
Newly formed SAB to provide direction as company advances mission to develop improved treatments for mental health and brain disordersMIAMI BEACH, Fla., Nov. 09, 2021 (GLOBE NEWSWIRE) — Pasithea Therapeutics Corp. (Nasdaq: KTTA) (“Pasithea” or the...
by divibasicbldev | Oct 27, 2021 | Press Releases
– Pasithea Clinics commences IV ketamine infusion therapy in Knightsbridge, London, for the treatment of mental health disorders -MIAMI BEACH, Fla., Oct. 27, 2021 (GLOBE NEWSWIRE) — Pasithea Therapeutics Corp. (Nasdaq: KTTA) (“Pasithea” or the...